450 related articles for article (PubMed ID: 17552362)
21. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
[TBL] [Abstract][Full Text] [Related]
22. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
Qi L; Robinson WA; Brady BM; Glode LM
Anticancer Res; 2003; 23(5A):3917-22. PubMed ID: 14666697
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
24. Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells.
Mulkeen AL; Silva T; Yoo PS; Schmitz JC; Uchio E; Chu E; Cha C
Arch Surg; 2006 Apr; 141(4):367-74; discussion 374. PubMed ID: 16618894
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
Pufe T; Harde V; Petersen W; Goldring MB; Tillmann B; Mentlein R
J Pathol; 2004 Mar; 202(3):367-74. PubMed ID: 14991903
[TBL] [Abstract][Full Text] [Related]
26. Expression of VEGF receptors in cocultured neuroblastoma cells.
Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK
J Surg Res; 2004 Jun; 119(1):56-65. PubMed ID: 15126083
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor in human glioma cells.
Zheng SX; Zhou LJ; Zhu XZ; Jin YX
Acta Pharmacol Sin; 2000 Mar; 21(3):211-4. PubMed ID: 11324417
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
Zhang L; Hannay JA; Liu J; Das P; Zhan M; Nguyen T; Hicklin DJ; Yu D; Pollock RE; Lev D
Cancer Res; 2006 Sep; 66(17):8770-8. PubMed ID: 16951193
[TBL] [Abstract][Full Text] [Related]
31. Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells.
Yang H; Li M; Chai H; Yan S; Zhang R; Yao Q; Chen C
J Surg Res; 2004 Dec; 122(2):249-55. PubMed ID: 15555625
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).
Schichor C; Birnbaum T; Etminan N; Schnell O; Grau S; Miebach S; Aboody K; Padovan C; Straube A; Tonn JC; Goldbrunner R
Exp Neurol; 2006 Jun; 199(2):301-10. PubMed ID: 16574102
[TBL] [Abstract][Full Text] [Related]
33. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects.
Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M
Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of expression of vascular endothelial growth factor and matrix matalloproteinase-2 to invasion of ovarian tumor cells in vitro].
Zhang AL; Wang SX; Lu YP; Li J; Wang CY; Ma D
Ai Zheng; 2002 Mar; 21(3):263-6. PubMed ID: 12451991
[TBL] [Abstract][Full Text] [Related]
36. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
37. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
38. [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].
Lu Y; Zhang A; Wang S; Li J; Wang C; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):294-7. PubMed ID: 12133405
[TBL] [Abstract][Full Text] [Related]
39. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
Bernatchez PN; Rollin S; Soker S; Sirois MG
J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
[TBL] [Abstract][Full Text] [Related]
40. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
